n(g),n(g')-dimethyl-l-arginine has been researched along with Muscle Contraction in 5 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Muscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.
Excerpt | Relevance | Reference |
---|---|---|
"These results strongly suggest that impaired endothelium dependent and NO mediated cavernous relaxation with aging is due to decreased NO production, which would result from increased arginase activity and probably from decreased L-arginine content." | 3.72 | Involvement of increased arginase activity in impaired cavernous relaxation with aging in the rabbit. ( Azuma, H; Kihara, K; Kurosaki, E; Masuda, H; Sakai, Y; Yamauchi, Y, 2004) |
"To establish the role played by the circulating nitric oxide synthase inhibitors N(G)-monomethyl-L-arginine (L-NMMA), asymmetrical dimethyl arginine (ADMA) and symmetric dimethyl arginine (SDMA) and its association with hypertension of children and adolescents." | 3.69 | Nitric oxide synthase inhibitors and hypertension in children and adolescents. ( Dillon, MJ; Frend, A; Goonasekera, CD; Rees, DD; Shah, V; Woolard, P, 1997) |
"Aspirin at the lower dose (30 mg/kg) protects the endothelium against damages elicited by LDL in vivo, and the protective effect of aspirin on endothelium is related to reduction of ADMA concentration by increasing DDAH activity." | 1.32 | Aspirin protected against endothelial damage induced by LDL: role of endogenous NO synthase inhibitors in rats. ( Deng, HD; Deng, PY; Deng, S; Jiang, JL; Li, YJ; Yang, TL; Ye, F; Yu, J, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cable, DG | 1 |
Celotto, AC | 1 |
Evora, PR | 1 |
Schaff, HV | 1 |
Galal, O | 1 |
Podlogar, J | 1 |
Verspohl, EJ | 1 |
Sakai, Y | 1 |
Masuda, H | 1 |
Kihara, K | 1 |
Kurosaki, E | 1 |
Yamauchi, Y | 1 |
Azuma, H | 1 |
Deng, S | 1 |
Deng, PY | 1 |
Jiang, JL | 1 |
Ye, F | 1 |
Yu, J | 1 |
Yang, TL | 1 |
Deng, HD | 1 |
Li, YJ | 1 |
Goonasekera, CD | 1 |
Rees, DD | 1 |
Woolard, P | 1 |
Frend, A | 1 |
Shah, V | 1 |
Dillon, MJ | 1 |
5 other studies available for n(g),n(g')-dimethyl-l-arginine and Muscle Contraction
Article | Year |
---|---|
Asymmetric dimethylarginine endogenous inhibition of nitric oxide synthase causes differential vasculature effects.
Topics: Animals; Arginine; Arteries; Dogs; Endothelium, Vascular; Enzyme Inhibitors; Humans; Muscle Contract | 2009 |
Impact of ADMA (asymmetric dimethylarginine) on physiology with respect to diabetes mellitus and respiratory system BEAS-2B cells (human bronchial epithelial cells).
Topics: Animals; Arginine; Blood Glucose; Cell Line; Chemokine CXCL2; Diabetes Mellitus; Epithelial Cells; F | 2013 |
Involvement of increased arginase activity in impaired cavernous relaxation with aging in the rabbit.
Topics: Aging; Animals; Arginase; Arginine; Carbachol; Cholinergic Agonists; Endothelium, Vascular; Male; Mu | 2004 |
Aspirin protected against endothelial damage induced by LDL: role of endogenous NO synthase inhibitors in rats.
Topics: Amidohydrolases; Animals; Aorta, Thoracic; Arginine; Aspirin; Dose-Response Relationship, Drug; Endo | 2004 |
Nitric oxide synthase inhibitors and hypertension in children and adolescents.
Topics: Adolescent; Animals; Arginine; Child; Endothelium, Vascular; Enzyme Inhibitors; Female; Glomerular F | 1997 |